Fir Tree Capital Management’s Envoy Medical COCH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-247,635
Closed -$2.56M 149
2023
Q3
$2.56M Sell
247,635
-152,365
-38% -$1.52M 0.27% 129
2023
Q2
$4.1M Hold
400,000
0.38% 103
2023
Q1
$4.02M Sell
400,000
-795,343
-67% -$7.97M 0.32% 117
2022
Q4
$12.1M Buy
1,195,343
+15,720
+1% +$156K 0.62% 42
2022
Q3
$11.6M Hold
1,179,623
0.39% 68
2022
Q2
$11.6M Sell
1,179,623
-31,767
-3% -$311K 0.36% 75
2022
Q1
$11.8M Hold
1,211,390
0.33% 86
2021
Q4
$11.8M Hold
1,211,390
0.32% 90
2021
Q3
$11.8M Hold
1,211,390
0.4% 66
2021
Q2
$11.8M Buy
+1,211,390
New +$11.8M 0.44% 60

Other funds holding COCH

Fir Tree Capital Management's COCH Position: Q4 2023 in Review

Fir Tree Capital Management sold out of Envoy Medical (COCH) in Q4 2023, closing a stake of 247,635 shares — an estimated $2.56M sold.

Fir Tree Capital Management first reported a position in COCH in Q2 2021 and held it in 10 quarters. The position peaked at $12.1M in Q4 2022. 9 funds tracked by Wall St. Rank hold COCH as of Q4 2023.

  • Fir Tree Capital Management reported no remaining Envoy Medical position as of Q4 2023 after selling out during the quarter.
  • Fir Tree Capital Management sold 247,635 Envoy Medical shares in Q4 2023, an estimated $2.56M.
  • Fir Tree Capital Management first reported a position in Envoy Medical in Q2 2021 and held it in 10 quarters.
  • Fir Tree Capital Management's Envoy Medical position peaked at $12.1M in Q4 2022.
  • 9 funds tracked by Wall St. Rank held Envoy Medical as of Q4 2023.

Based on Fir Tree Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.